NSCLC ADENOCARCINOMA

Clinical trials for NSCLC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for NSCLC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Experimental cancer combo aims to supercharge immune attack on tumors

Disease control Ongoing

This early-phase trial tests an experimental drug called IMP321, which activates immune cells, in combination with other cancer treatments like chemotherapy or immunotherapy. The study includes 83 people with advanced solid tumors, including lung and bladder cancers. The main goa…

Matched conditions: NSCLC ADENOCARCINOMA

Phase: PHASE1 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control

Last updated Jun 27, 2026 09:05 UTC

NSCLC ADENOCARCINOMA

Get alerted when new NSCLC ADENOCARCINOMA trials appear

Experimental cancer combo aims to supercharge immune attack on tumors